Tart Cherry for Gout

Verdict: Disputed, weak evidence; trials show no benefit

Evidence that tart cherry lowers uric acid or prevents gout flares is weak and conflicting: the positive signal comes only from observational data, while the better-controlled trials found no benefit. It is not a reliable treatment, and acute gout still requires medication.

C 🟠 C Weak Evidence Disputed

🔬Why this grade7-layer evidence engine

The grade is held to weak, disputed evidence because the studies pull in opposite directions. The main positive signal is the Zhang 2012 case-crossover study (PMID 23023818, n=633), which linked cherry intake to fewer recurrent gout attacks, and a 2019 systematic review (PMID 31885677, n=941) that found a supportive association but whose heterogeneity prevented a pooled meta-analysis. Both are observational and rely on self-reported intake without serum urate data, so they can show association but not cause.

Crucially, the better-designed trials are negative. A 2020 dose-ranging randomized trial (PMID 31891407, n=50) found no effect of tart cherry concentrate on serum urate, urate excretion, or flare frequency at any dose, and a 2023 randomized trial (PMID 37679816, n=282) showed a tart cherry citrate mixture did not outperform comparators on uric acid. Controlled trials therefore do not confirm a urate-lowering or flare-reducing benefit.

Authorities are correspondingly reserved. Mayo Clinic and Harvard Health note only that some studies 'may' lower flare risk while stressing that diet rarely lowers urate enough to treat gout; rheumatology guidelines make no recommendation, citing low certainty. Regulators are stricter still: the US FDA has acted against cherry products marketed as treating gout, treating such claims as unapproved drug claims, and EFSA has authorised no EU health claim. Cherries are safe to eat, but should be seen as a minor adjunct, not a therapy.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.51
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
C · Disputed
Confidence
68%
Broadly consistent
Evidence level
E3
Single high-quality meta-analysis

How strongly each layer supports this effect

lower = less supportive
L2 PubMedPrimary literature
0.45
L3 MechanismPlausibility
0.45
L1 ExamineGlobal benchmark
0.50
L11 AI re-checkIndependent read
0.50
L5 Clinical bodiesAuthoritative stance
0.65
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.51
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (1 篇 > 0 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 2 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (4)L2 · primary research & systematic reviews

Cherry consumption and decreased risk of recurrent gout attacks
PMID: 23023818 2012 Observational n = 633
Finding: Cherry intake over a 2-day period was associated with a 35% lower risk of gout attacks (OR 0.65, 95% CI 0.50-0.85); cherry extract alone OR 0.55; benefit plateaued at ~3 servings; combining cherry intake with allopurinol gave a 75% lower risk (OR 0.25, 95% CI 0.15-0.42). Serum uric acid data were unavailable.
🟠 Limited quality Government Effect size: OR 0.65 (fresh cherries); OR 0.55 (extract); OR 0.25 (cherry + allopurinol)
View on PubMed
Lack of effect of tart cherry concentrate dose on serum urate in people with gout
PMID: 31891407 2020 隨機對照試驗 n = 50
Finding: Cherry concentrate dose had no significant effect on reduction in serum urate AUC (p=0.76), urine urate excretion, or frequency of gout flares over the 28-day period.
Government Effect size: No significant effect at any dose
View on PubMed
Efficacy and safety of tart cherry supplementary citrate mixture on gout patients: a prospective, randomized, controlled study
PMID: 37679816 2023 RCT (open-label) n = 282
Finding: Urine pH and serum urate declined similarly across all three groups with no between-group difference. The TaCCi and citrate-mixture groups had fewer gout flares than the sodium bicarbonate group (p<0.05); the TaCCi group showed greater improvement in urinary albumin/creatinine ratio and C-reactive protein (p<0.01).
Effect size: No serum urate difference vs comparators; fewer flares vs bicarbonate (p<0.05)
View on PubMed
Effectiveness of Cherries in Reducing Uric Acid and Gout: A Systematic Review
PMID: 31885677 2019 系統性回顧 n = 941
Finding: Across 6 heterogeneous studies (~941 participants) current evidence supports an association between cherry intake and reduced gout attack risk; one study reported a 35% reduction in recurrent attacks and another a 19.2% reduction in serum uric acid. Heterogeneity precluded meta-analysis.
🟠 Limited quality Effect size: Association only; up to 35% lower attack risk, ~19% lower serum uric acid in individual studies
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Cautious
articles intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in man... are drugs source↗
L4b EU EFSA
Against
L4d TW TFDA / 衛福部
Neutral
L5a NIH Office of Dietary Supplements
Cautious
L5b Mayo Clinic
Cautious
Some studies show that eating cherries may lower the risk of gout attacks. source↗
L5c Cleveland Clinic
Supportive
L5d Harvard Health
Cautious
L5e Specialty Society (condition-mapped)
Supportive
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬4 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-gout-INT-tart-cherry-001 繁體中文版 →